Santa Maria incubator to provide needed help
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Sientra selling implants again but staff cut as losses mount
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Tri-county entrepreneurs debate value of patents
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Stellar Biotechnologies forming Paris-based company in joint venture
Stellar Biotechnologies will form a Paris-based company in a joint venture with Neovacs. The companies announced the partnership May 11. Neovacs, which is based in Paris, will own 70 percent of the new company, called Neostell. Stellar Biotechnologies will own 30 percent. Based in Port Hueneme, Stellar Biotechnologies makes a protein for immunotherapy treatments using Read More →
Read More →Resonant finally gets revenue but still had big second quarter operating loss
Resonant is no longer pre-revenue. The Goleta-based company, which is developing smartphone technology called duplexers it intends to license to manufacturers of smartphone technology, recorded revenues of $27,000 when it released second quarter earnings May 11. The company said the money came from two customers who made upfront payments on two upcoming projects. The company Read More →
Read More →Stellar Biotechnologies revenues nearly doubled in first quarter
Stellar Biotechnologies revenues nearly doubled but so did the company’s losses during the first quarter, the Port Hueneme biotech company reported May 9. Stellar Biotechnologies makes a protein for immunotherapy treatments using a unique sea snail only found off the coastal shores of a small part of California. The company’s revenues increased from $187,627 during Read More →
Read More →Goleta-based Inogen beats revenue estimates for first quarter
Goleta-based Inogen beat revenue estimates and the maker of direct-to-consumer respiratory products reported strong first quarter earnings results May 9. Inogen reported revenues of $43 million during the first quarter, up from $33.8 million in 2015 and beating analyst estimates of $41.75 million, according to S&P Capital IQ. The company had net income of $2.4 Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
